An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors

In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and...

Full description

Bibliographic Details
Main Authors: Huiding Xie, Yupeng Li, Fang Yu, Xiaoguang Xie, Kaixiong Qiu, Jijun Fu
Format: Article
Language:English
Published: MDPI AG 2015-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/16/11/26026
id doaj-70eb68b5f73e4ceaa06da0d6a20fc879
record_format Article
spelling doaj-70eb68b5f73e4ceaa06da0d6a20fc8792020-11-25T01:13:01ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-11-011611273502736110.3390/ijms161126026ijms161126026An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase InhibitorsHuiding Xie0Yupeng Li1Fang Yu2Xiaoguang Xie3Kaixiong Qiu4Jijun Fu5Department of Chemistry, Yunnan University, Kunming 650091, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaDepartment of Chemistry, Yunnan University, Kunming 650091, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaDepartment of Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, ChinaIn the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔGbind) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔGbind was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔGbind, and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors.http://www.mdpi.com/1422-0067/16/11/26026imidazopyridineB-Raf kinasemolecular dockingmolecular dynamic simulation
collection DOAJ
language English
format Article
sources DOAJ
author Huiding Xie
Yupeng Li
Fang Yu
Xiaoguang Xie
Kaixiong Qiu
Jijun Fu
spellingShingle Huiding Xie
Yupeng Li
Fang Yu
Xiaoguang Xie
Kaixiong Qiu
Jijun Fu
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
International Journal of Molecular Sciences
imidazopyridine
B-Raf kinase
molecular docking
molecular dynamic simulation
author_facet Huiding Xie
Yupeng Li
Fang Yu
Xiaoguang Xie
Kaixiong Qiu
Jijun Fu
author_sort Huiding Xie
title An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_short An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_full An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_fullStr An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_full_unstemmed An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
title_sort investigation of molecular docking and molecular dynamic simulation on imidazopyridines as b-raf kinase inhibitors
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2015-11-01
description In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (ΔGbind) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, ΔGbind was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to ΔGbind, and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors.
topic imidazopyridine
B-Raf kinase
molecular docking
molecular dynamic simulation
url http://www.mdpi.com/1422-0067/16/11/26026
work_keys_str_mv AT huidingxie aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT yupengli aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT fangyu aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT xiaoguangxie aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT kaixiongqiu aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT jijunfu aninvestigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT huidingxie investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT yupengli investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT fangyu investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT xiaoguangxie investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT kaixiongqiu investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
AT jijunfu investigationofmoleculardockingandmoleculardynamicsimulationonimidazopyridinesasbrafkinaseinhibitors
_version_ 1725163744919552000